Profilo
Meryle J.
Melnicoff is currently the Director at Friendship Bridge and the Director-Business Development at The Wistar Institute.
Previously, she worked as an Advisor at Ben Franklin Technology Partners.
Melnicoff received graduate and doctorate degrees from the University of Pennsylvania.
Posizioni attive di Meryle J. Melnicoff
| Società | Posizione | Inizio |
|---|---|---|
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology Provides biomedical research services | Corporate Officer/Principal | - |
Friendship Bridge
Friendship Bridge Services to the Health IndustryHealth Services Operates charitable organization that creates opportunities to empower women | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Meryle J. Melnicoff
| Società | Posizione | Fine |
|---|---|---|
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Membro del Comitato di Investimento | - |
Formazione di Meryle J. Melnicoff
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Friendship Bridge
Friendship Bridge Services to the Health IndustryHealth Services Operates charitable organization that creates opportunities to empower women | Health Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology Provides biomedical research services | Health Technology |
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Finance |
















